SCHEMBL6692486

SCHEMBL6692486

CO[C@H]1CN[C@](Cc2ccccc2)(C(=O)N2CCC(Cc3ccccc3)CC2)C1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
MAPK14 Q16539 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.46
KMT2A Q03164 7/20 0.46
MEN1 O00255 6/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
HTR2B P41595 1/20 0.45
NPC1 O15118 1/20 0.45
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659083 0.85 FAAH (0.47) CYP2C9CYP2C19MAPK14ALDH1A1LMNA
SCHEMBL6659777 0.72 HRH3 (0.57) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
Hydrochloric Acid SCHEMBL6662221 0.71 HRH3 (0.62) CYP2C9CYP2C19MAPK14ALDH1A1KMT2A
SCHEMBL3026559 0.70 CYP2C9 (0.67) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL4576736 0.70 L3MBTL1 (0.69) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL13589533 0.69 L3MBTL1 (0.68) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL2636547 0.68 MEN1 (0.68) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL6692489 0.67 CYP2C9 (0.50) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL6684723 0.67 CYP2C9 (0.50) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL6692481 0.67 CYP2C9 (0.50) L3MBTL1CYP2C9CYP2C19MAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441728-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY Vertex Pharmaceuticals Incorporated (US) 2004-08-04 EP disclosed
WO-2003037338-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-05-08 WO disclosed